期刊
LEUKEMIA & LYMPHOMA
卷 43, 期 12, 页码 2331-2334出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/1042819021000040035
关键词
T-cell prolymphocytic leukemia; purine analogues; CD25; CD38; CD103
T-cell prolymphocytic leukemia (T-PLL) is a rare lymphoproliferative disorder with distinctive clinical and laboratory features. It is often resistant to conventional chemotherapy, but complete or partial responses have been documented with the use of purine analogues. We report on two cases of T-PLL with a slightly different immunophenotype but a remarkably different response to pentostatin. We discuss the possible therapeutic implications of this finding and establish a comparison between immunophenotype and sensitivity to purine analogues in patients with T-PLL and other chronic lymphoproliferative disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据